CDK4/6 (a subgroup of CDKs) has been shown to play a role in BC pathogenesis with the overexpression of cyclin D1 found in 50% of all BC cases leading to aberrant phosphorylation of Rb and irreversible cell cycle progression [13]. The gene discussed is RB1; the disease is breast cancer.